FDA Could Face 13% Funding Cut Under House FY '12 Appropriations Bill
House Republicans' proposal to cut funding in the fiscal year 2012 Agriculture/FDA appropriations bill by 13% would cost FDA about $475 million if it applied across the board to both USDA and FDA.
You may also be interested in...
National Institutes of Health Director Francis Collins expects to send, "in the fairly near future," detailed plans to Congress for shifting existing translational research projects into a new National Center for Advancing Translational Research.
FDA seems content to negotiate a user fee for biosimilars in a manner that typifies the composition of the products: similar, but not the same, as the other user fee programs.
FDA does not want to rush, but may consider splitting negotiators into small groups to deal with specific issues.